The American Cancer Society Cancer Action Network is hosting a half-day conference exploring the challenges of equitable pharmacogenomics research and testing for cancer patients.

Alexion/AstraZeneca Rare Disease, the EveryLife Foundation for Rare Diseases, the National Society of Genetic Counselors, and the Personalized Medicine Coalition will convene a reception with Congressional leaders and rare disease experts on Tuesday, July 18, at 5:30 p.m. to discuss how Congress, patient advocates, and industry leaders can work together to deliver faster diagnoses for rare disease patients. The reception will take place in Room 2322 of the Rayburn building. RSVP to Gwen Fuller at gfuller@forbes-tate.com.